Gain Therapeutics Announces 2024 R&D Update on Parkinson's D

Event, moderated by Hartaj Singh and Eka Gigauri of Oppenheimer & Co., will be held on Thursday, February 22, 2024 at 11:00 am ESTBETHESDA, Md., Feb. 14, 2024 -- Gain Therapeutics, Inc., , a...

Related Keywords

Germany , Israel , Tel Aviv , Hartaj Singh , Joanne Taylor , Eka Gigauri , Roy Alcalay , Matthias Alder , Elio Ambrosio , Nic Johnson , Tiago Fleming Outeiro , Oppenheimer Co , Columbia University , Company Annual Report On Form , Movement Disorder Society , Gain Therapeutics Inc , Department Of Experimental Neurodegeneration , Linkedin , Nasdaq , Silverstein Foundation For Parkinson , Michaelj Fox Foundation For Parkinson Research , Professor At Newcastle University , University Medical Center , Exchange Commission On , Exchange Commission , Research Development , Key Opinion , Symptomatic Treatment , Gain Therapeutics Rd Update , Senior Vice President , Movement Disorders Division , Tel Aviv Sourasky Medical Center , Foundation Funded Parkinson , Progression Markers Initiative , Experimental Neurodegeneration , Task Force , Biological Definition , Internation Parkinson , Movement Disorder , Silverstein Foundation , Gain Therapeutics , Site Directed Enzyme Enhancement Therapy , Private Securities Litigation Reform Act , Annual Report , Markets ,